Related references
Note: Only part of the references are listed.Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Veronica Fernandez et al.
CANCER RESEARCH (2010)
Time to Treatment Does Not Influence Overall Survival in Newly Diagnosed Mantle-Cell Lymphoma
Heather E. Eve et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
Peter Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity
Margit Schraders et al.
MODERN PATHOLOGY (2009)
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Eva Hoster et al.
BLOOD (2008)
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL):: a clinicopathological study from the European MCL Network
M Tiemann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
IgVH mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome
SB Cogliatti et al.
JOURNAL OF PATHOLOGY (2005)
Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research
F Bertoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
The leukemic presentation of mantle-cell lymphoma: Disease features and prognostic factors in 58 patients
E Matutes et al.
LEUKEMIA & LYMPHOMA (2004)
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma:: correlation with genomic aberrations, clinical characteristics, and outcome
D Kienle et al.
BLOOD (2003)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease
J Orchard et al.
BLOOD (2003)
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations
FI Camacho et al.
BLOOD (2003)
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma
JE Romaguera et al.
CANCER (2003)
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald et al.
CANCER CELL (2003)
Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia
R Ruchlemer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
The splenic form of mantle cell lymphoma
MK Angelopoulou et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphoma
Y Yoong et al.
LEUKEMIA & LYMPHOMA (2001)
Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome
TJ Molina et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)
Share Paper
